Basal Serum Thyroglobulin Measured by a Second-Generation Assay Is Equivalent to Stimulated Thyroglobulin in Identifying Metastases in Patients with Differentiated Thyroid Cancer with Low or Intermediate Risk of Recurrence

Publisher： Karger

E-ISSN： 2235-0802|3|1|43-50

ISSN： 2235-0640

Source： European Thyroid Journal, Vol.3, Iss.1, 2014-03, pp. : 43-50

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Should Age at Diagnosis Be Included as an Additional Variable in the Risk of Recurrence Classification System in Patients with Differentiated Thyroid Cancer

By  

European Thyroid Journal, Vol. 6, Iss. 3, 2017-01 ,pp. : 160-166

Karger

Access to resources Recommend Favorite

Can the American Thyroid Association Risk of Recurrence Predict Radioiodine Refractory Disease in Differentiated Thyroid Cancer?

By  

European Thyroid Journal, Vol. 5, Iss. 4, 2016-10 ,pp. : 261-267

Karger

Access to resources Recommend Favorite

Large Discrepancy in the Results of Sensitive Measurements of Thyroglobulin Antibodies in the Follow-Up on Thyroid Cancer: A Diagnostic Dilemma

By  

European Thyroid Journal, Vol. 1, Iss. 3, 2012-08 ,pp. : 193-197

Karger

Access to resources Recommend Favorite

A Prospective Study Showing an Excellent Response of Patients with Low-Risk Differentiated Thyroid Cancer Who Did Not Undergo Radioiodine Remnant Ablation after Total Thyroidectomy

By  

European Thyroid Journal, Vol. 5, Iss. 1, 2015-11 ,pp. : 44-49

Karger

Access to resources Recommend Favorite

Development and Application of a Novel Sensitive Immunometric Assay for Calcitonin in a Large Cohort of Patients with Medullary and Differentiated Thyroid Cancer, Thyroid Nodules, and Autoimmune Thyroid Diseases

By  

European Thyroid Journal, Vol. 3, Iss. 2, 2014-06 ,pp. : 117-124

Karger

Access to resources Recommend Favorite